Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

8 study records (showing up to 30 per record type)

• Registered trial NCT02760901 Phase 2 Completed (results not assessed here)
  Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity
  Condition or outcome area: Cisplatin Nephrotoxicity
  2013-11 · Subject: MTL; Mannitol; d-mannitol; Osmitrol; Mannitol (VAN); 123897-58-5; M9546_SIAL; NCI-C50362; Mannidex; SDM No. 35 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00356954 Phase 4 Completed (results not assessed here)
  NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization
  Condition or outcome area: Kidney Failure
  2005-02 · Subject: L-Ascorbic Acid; Ascorbic acid; l-ascorbic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01550432 Completed (results not assessed here)
  Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation
  Condition or outcome area: Obesity|Hyperlipidemia|Insulin Resistance|Hypertension
  2011-06 · Subject: Glutathion; Glutathione · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02141620 Early_Phase 1 Completed (results not assessed here)
  n-Acetylcysteine and Cocaine
  Condition or outcome area: Cocaine Abuse|Cocaine Dependence
  2014-05 · Subject: Cocaine; (-)Cocaine; 2alpha-Carbomethoxy-3beta-(benzoyloxy)tropane; 8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R,2R,3S,5S)-; 1alphaH,5alphaH-Tropane-2beta-carboxylic acid, 3beta-hydroxy-, methyl ester, benzoate (ester); Ecgonine methyl ester benzoate (ester) · open the ingredient record · ClinicalTrials.gov
• Systematic review registration CRD42019138299 Registered protocol, no results here: Review Completed published
  Effectiveness of N-acetylcysteine in Autism Spectrum Disorders: A Meta-analysis of randomized Controlled Trials
  Condition or outcome area: We examine the common outcomes used in clinical practice including the abberant behavior checklist (ABC), Social Responsiveness Scale (SRS), and the Repetitive Behavior Scale – Revised (RBS-R).
  2019-08-08 · Subject: Fcy; Cysteine; L-cysteine; 52-90-4; cysteine; Cystein; (R)-2-Amino-3-mercaptopropanoic acid; (R)-Cysteine; Thioserine; Half-cystine · open the ingredient record
• Systematic review registration CRD42017075921 Registered protocol, no results here: Review Ongoing
  Antimicrobial capacity of the N-acetylcysteine compared with calcium hydroxide: a narrative review
  Condition or outcome area: Endodontic pathology is mediated by microorganisms that are located within the root canal, and adhere to the root surface by means of different structures (virulence factors) which promote the development and formation of microcolonies known as biofilms. These biofilms play an important role in both pulp and periradicular pathologies, and for this reason, the objective of endodontic treatment is to eliminate the bacterial load present in the root canal by means of adequate preparation, conformat
  2017-10-17 · Subject: Calcium; 7440-70-2; Ca; Elemental calcium; Calcium, elemental; HSDB 273; UNII-SY7Q814VUP; SY7Q814VUP; EINECS 231-179-5; Kalzium · open the ingredient record
• Systematic review registration CRD42020156946 Registered protocol, no results here: Review Completed published
  Cimetidine, fomepizole, or calmangafodipir in patients with acetaminophen (paracetamol) poisoning treated with IV N-acetylcysteine.
  Condition or outcome area: Severe acetaminophen (paracetamol) poisoning
  2020-04-28 · Subject: 4-methylpyrazole; Fomepizole; fomepizole; 4-Methyl-1H-pyrazole; 7554-65-6; Antizol; 1H-Pyrazole, 4-methyl-; 4-Methylpyrazol; Fomepizol; Fomepizolum · open the ingredient record
• Publication PMID 34202008 Research model: Animal & Cell Experiment
  Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane N-acetylcysteine
  Condition or outcome area: fibrosis
  Pharmaceutics · 2021 · Subject: Sulforathane; Sulforaphane; sulforaphane; 4478-93-7; DL-Sulforaphane; 1-Isothiocyanato-4-(methylsulfinyl)butane; D,L-Sulforaphane; Sulforafan; 1-isothiocyanato-4-methylsulfinylbutane; 1-Isothiocyanato-4-(methylsulfinyl)-butane · open the ingredient record · DOI 10.3390/pharmaceutics13070958